

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.38338798 |
| 2 | central nervous system myelination (GO:0022010) | 5.38338798 |
| 3 | fatty acid elongation (GO:0030497) | 5.17940989 |
| 4 | amyloid precursor protein catabolic process (GO:0042987) | 4.16732371 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.02102825 |
| 6 | negative regulation of cell killing (GO:0031342) | 3.83594683 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83594683 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66250918 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66250918 |
| 10 | virion attachment to host cell (GO:0019062) | 3.63691701 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 3.63691701 |
| 12 | cholesterol biosynthetic process (GO:0006695) | 3.60871565 |
| 13 | response to peptidoglycan (GO:0032494) | 3.60852709 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.59134260 |
| 15 | amyloid precursor protein metabolic process (GO:0042982) | 3.56319988 |
| 16 | creatine metabolic process (GO:0006600) | 3.47585388 |
| 17 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.44396972 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37206738 |
| 19 | neutrophil mediated immunity (GO:0002446) | 3.32474235 |
| 20 | positive regulation of heat generation (GO:0031652) | 3.29726777 |
| 21 | regulation of germinal center formation (GO:0002634) | 3.28953005 |
| 22 | axon ensheathment (GO:0008366) | 3.24399758 |
| 23 | ensheathment of neurons (GO:0007272) | 3.24399758 |
| 24 | RNA destabilization (GO:0050779) | 3.21112889 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.18728023 |
| 26 | myelin maintenance (GO:0043217) | 3.18260296 |
| 27 | myelination (GO:0042552) | 3.18161374 |
| 28 | signal peptide processing (GO:0006465) | 3.17250390 |
| 29 | sterol biosynthetic process (GO:0016126) | 3.17197270 |
| 30 | tolerance induction (GO:0002507) | 3.11442676 |
| 31 | membrane protein ectodomain proteolysis (GO:0006509) | 3.04606924 |
| 32 | positive regulation of interleukin-17 production (GO:0032740) | 3.02716230 |
| 33 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.99341516 |
| 34 | adhesion of symbiont to host (GO:0044406) | 2.97175258 |
| 35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96437812 |
| 36 | leukocyte aggregation (GO:0070486) | 2.93518297 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 2.88744392 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88744392 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 2.88744392 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88744392 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88744392 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88744392 |
| 43 | regulation of fever generation (GO:0031620) | 2.88319768 |
| 44 | nucleotide transmembrane transport (GO:1901679) | 2.84794051 |
| 45 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.84303834 |
| 46 | regulation of mast cell activation (GO:0033003) | 2.83073001 |
| 47 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.82180468 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82048768 |
| 49 | membrane raft organization (GO:0031579) | 2.81902146 |
| 50 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.81616025 |
| 51 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.81328188 |
| 52 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.79804886 |
| 53 | regulation of heat generation (GO:0031650) | 2.78475675 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77882433 |
| 55 | regulation of collateral sprouting (GO:0048670) | 2.75418611 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.75369880 |
| 57 | dendritic cell migration (GO:0036336) | 2.75136426 |
| 58 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.74967202 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74909572 |
| 60 | positive regulation of actin filament depolymerization (GO:0030836) | 2.74485190 |
| 61 | positive regulation of prostaglandin secretion (GO:0032308) | 2.71285696 |
| 62 | neutrophil activation (GO:0042119) | 2.70521901 |
| 63 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.69735757 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68471720 |
| 65 | myeloid cell homeostasis (GO:0002262) | 2.66735573 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66708295 |
| 67 | macrophage activation (GO:0042116) | 2.65822291 |
| 68 | negative regulation of interleukin-12 production (GO:0032695) | 2.64850568 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 2.64570511 |
| 70 | response to lipoprotein particle (GO:0055094) | 2.62615945 |
| 71 | granulocyte activation (GO:0036230) | 2.61717225 |
| 72 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.61283498 |
| 73 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.61045473 |
| 74 | positive regulation of pseudopodium assembly (GO:0031274) | 2.60827166 |
| 75 | respiratory burst (GO:0045730) | 2.59320076 |
| 76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.59261376 |
| 77 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.58391921 |
| 78 | intracellular pH reduction (GO:0051452) | 2.57577919 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.56881173 |
| 80 | positive regulation of osteoclast differentiation (GO:0045672) | 2.56777189 |
| 81 | myeloid leukocyte mediated immunity (GO:0002444) | 2.56436923 |
| 82 | negative regulation of interleukin-1 production (GO:0032692) | 2.55671787 |
| 83 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.55635570 |
| 84 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.54736058 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.54707258 |
| 86 | dendritic cell chemotaxis (GO:0002407) | 2.53611763 |
| 87 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.53261314 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 2.51944679 |
| 89 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.51327660 |
| 90 | glycosylceramide metabolic process (GO:0006677) | 2.50858158 |
| 91 | germinal center formation (GO:0002467) | 2.50559751 |
| 92 | regulation of cellular extravasation (GO:0002691) | 2.50295595 |
| 93 | cellular extravasation (GO:0045123) | 2.47973022 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47964961 |
| 95 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.47937594 |
| 96 | negative regulation of lipid storage (GO:0010888) | 2.47352066 |
| 97 | regulation of metalloenzyme activity (GO:0048552) | 2.46206166 |
| 98 | L-phenylalanine catabolic process (GO:0006559) | 2.45812662 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.45812662 |
| 100 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.45172767 |
| 101 | regulation of lipoprotein metabolic process (GO:0050746) | 2.45124664 |
| 102 | regulation of T cell migration (GO:2000404) | 2.44290548 |
| 103 | actin nucleation (GO:0045010) | 2.44224887 |
| 104 | positive regulation of B cell differentiation (GO:0045579) | 2.44111409 |
| 105 | B cell mediated immunity (GO:0019724) | 2.44092234 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 2.43854037 |
| 107 | T-helper 1 type immune response (GO:0042088) | 2.43651452 |
| 108 | very long-chain fatty acid metabolic process (GO:0000038) | 2.43534701 |
| 109 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.43362935 |
| 110 | T-helper cell differentiation (GO:0042093) | 2.43155097 |
| 111 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.43155097 |
| 112 | membrane protein proteolysis (GO:0033619) | 2.43068457 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.41854737 |
| 114 | microglial cell activation (GO:0001774) | 2.41465996 |
| 115 | regulation of interleukin-17 production (GO:0032660) | 2.40781298 |
| 116 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.40033178 |
| 117 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.39705122 |
| 118 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.39502473 |
| 119 | macrophage activation involved in immune response (GO:0002281) | 2.39110526 |
| 120 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.38809400 |
| 121 | isoprenoid biosynthetic process (GO:0008299) | 2.38768460 |
| 122 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.38194550 |
| 123 | protein K11-linked deubiquitination (GO:0035871) | 2.37449535 |
| 124 | defense response to protozoan (GO:0042832) | 2.37355702 |
| 125 | positive regulation of interleukin-2 production (GO:0032743) | 2.37223573 |
| 126 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.36666285 |
| 127 | DNA deamination (GO:0045006) | 2.36075552 |
| 128 | negative regulation of innate immune response (GO:0045824) | 2.35790765 |
| 129 | detection of bacterium (GO:0016045) | 2.35733899 |
| 130 | regulation of regulatory T cell differentiation (GO:0045589) | 2.34076010 |
| 131 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.33180578 |
| 132 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.32910878 |
| 133 | positive regulation of mast cell degranulation (GO:0043306) | 2.32910878 |
| 134 | myeloid leukocyte activation (GO:0002274) | 2.32853805 |
| 135 | response to protozoan (GO:0001562) | 2.32475881 |
| 136 | regulation of interleukin-8 secretion (GO:2000482) | 2.31664497 |
| 137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.31216017 |
| 138 | platelet dense granule organization (GO:0060155) | 2.30271804 |
| 139 | regulation of memory T cell differentiation (GO:0043380) | 2.30238855 |
| 140 | mast cell activation (GO:0045576) | 2.28971093 |
| 141 | hepatocyte apoptotic process (GO:0097284) | 2.28700616 |
| 142 | response to interleukin-15 (GO:0070672) | 2.28553067 |
| 143 | phagosome maturation (GO:0090382) | 2.28447376 |
| 144 | immunoglobulin mediated immune response (GO:0016064) | 2.27924704 |
| 145 | positive regulation of T cell migration (GO:2000406) | 2.27567061 |
| 146 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.26842935 |
| 147 | neutrophil chemotaxis (GO:0030593) | 2.25801132 |
| 148 | myeloid cell activation involved in immune response (GO:0002275) | 2.25412697 |
| 149 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.25394096 |
| 150 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.24401601 |
| 151 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.24007982 |
| 152 | vesicle fusion (GO:0006906) | 2.23759979 |
| 153 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.22035453 |
| 154 | regulation of lymphocyte migration (GO:2000401) | 2.20419568 |
| 155 | pH reduction (GO:0045851) | 2.19760349 |
| 156 | autophagic vacuole fusion (GO:0000046) | 2.19313329 |
| 157 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.19008512 |
| 158 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.19008512 |
| 159 | leukocyte degranulation (GO:0043299) | 2.18907509 |
| 160 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.18491544 |
| 161 | regulation of pseudopodium assembly (GO:0031272) | 2.18330228 |
| 162 | positive regulation of interferon-alpha production (GO:0032727) | 2.17778791 |
| 163 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.16349476 |
| 164 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.15912589 |
| 165 | GPI anchor biosynthetic process (GO:0006506) | 2.14704091 |
| 166 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.14535394 |
| 167 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.13944914 |
| 168 | regulation of interferon-alpha production (GO:0032647) | 2.13638326 |
| 169 | regulation of superoxide anion generation (GO:0032928) | 2.13220771 |
| 170 | sphingosine metabolic process (GO:0006670) | 2.13072069 |
| 171 | detection of other organism (GO:0098543) | 2.10982461 |
| 172 | L-phenylalanine metabolic process (GO:0006558) | 2.10007541 |
| 173 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.10007541 |
| 174 | response to muramyl dipeptide (GO:0032495) | 2.09797058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.34249787 |
| 2 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.30609850 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64740824 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.31185727 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28049911 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.26314009 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.20418765 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70077965 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69209631 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.68610016 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64752269 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.62738719 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57789978 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.47674543 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.43984933 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35251884 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.20979997 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17274849 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15036874 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14628777 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07755429 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.07263622 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01104736 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99500792 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97594658 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.96003832 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91675579 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89531753 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87067911 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82202082 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.76894660 |
| 32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.72828845 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67996367 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.67932041 |
| 35 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.67003459 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.65884528 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64247784 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62275264 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57165045 |
| 40 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56306349 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55264535 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54508679 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53058434 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50940644 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50380707 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.49748145 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49303733 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49034850 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43205221 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42355353 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40921136 |
| 52 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40549059 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40513764 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36991954 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36416884 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36046083 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35911647 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35345967 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34990148 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33246473 |
| 61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32819333 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32197348 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29382614 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29168597 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26833494 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26745022 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26745022 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25772191 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.24602909 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24287145 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23325829 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22911231 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22254472 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21584880 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.18561356 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18029703 |
| 77 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16761720 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16743051 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16670592 |
| 80 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16540675 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.16108793 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15226687 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15226687 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13835083 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13536643 |
| 86 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.13003624 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11664486 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10935077 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09755842 |
| 90 | MYB_26560356_Chip-Seq_TH1_Human | 1.09252947 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.09237385 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.08406006 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08146990 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05995322 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05968203 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04170199 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03763663 |
| 98 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.02668752 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01384799 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01105851 |
| 101 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01033194 |
| 102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00682897 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00073754 |
| 104 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99800026 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99008703 |
| 106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98890131 |
| 107 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98144075 |
| 108 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96214034 |
| 109 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95172758 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.94866496 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93872663 |
| 112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93302732 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92625160 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92486762 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90794156 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90524921 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89814236 |
| 118 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89774934 |
| 119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89774934 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89553631 |
| 121 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89207819 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89142569 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88277690 |
| 124 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87843933 |
| 125 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.87796220 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.87189760 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87065967 |
| 128 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86244992 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86231068 |
| 130 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86152547 |
| 131 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85766599 |
| 132 | UTX_26944678_Chip-Seq_JUKART_Human | 0.85751658 |
| 133 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85607452 |
| 134 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85478145 |
| 135 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.83074246 |
| 136 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82625117 |
| 137 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.82492734 |
| 138 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82132824 |
| 139 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79165411 |
| 140 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78472163 |
| 141 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.78472163 |
| 142 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77294187 |
| 143 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.76621604 |
| 144 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76562739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 2.96824339 |
| 2 | MP0009785_altered_susceptibility_to | 2.76797070 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.75317672 |
| 4 | MP0003724_increased_susceptibility_to | 2.75182391 |
| 5 | MP0000685_abnormal_immune_system | 2.47682172 |
| 6 | MP0005671_abnormal_response_to | 2.47227738 |
| 7 | MP0006082_CNS_inflammation | 2.44155957 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.31182114 |
| 9 | MP0003436_decreased_susceptibility_to | 2.31051900 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.30797200 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.22568148 |
| 12 | MP0005387_immune_system_phenotype | 2.19262816 |
| 13 | MP0001790_abnormal_immune_system | 2.19262816 |
| 14 | MP0005025_abnormal_response_to | 2.16278109 |
| 15 | MP0002419_abnormal_innate_immunity | 2.14192638 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.06309725 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.04435979 |
| 18 | MP0004381_abnormal_hair_follicle | 2.02774717 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.00952331 |
| 20 | MP0002009_preneoplasia | 1.98895244 |
| 21 | MP0009840_abnormal_foam_cell | 1.97742219 |
| 22 | MP0002723_abnormal_immune_serum | 1.91425920 |
| 23 | MP0003690_abnormal_glial_cell | 1.91144224 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.87710440 |
| 25 | MP0003195_calcinosis | 1.86937963 |
| 26 | MP0006054_spinal_hemorrhage | 1.85776859 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.83377743 |
| 28 | MP0003828_pulmonary_edema | 1.81706449 |
| 29 | MP0004947_skin_inflammation | 1.77013077 |
| 30 | MP0001800_abnormal_humoral_immune | 1.73817209 |
| 31 | MP0002006_tumorigenesis | 1.73322394 |
| 32 | MP0001819_abnormal_immune_cell | 1.69351185 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.69283212 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.69089194 |
| 35 | MP0002933_joint_inflammation | 1.68373123 |
| 36 | MP0000383_abnormal_hair_follicle | 1.61294847 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.61036233 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.55471346 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.54734088 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.53994197 |
| 41 | MP0005451_abnormal_body_composition | 1.50695881 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.50415761 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.49247950 |
| 44 | MP0003186_abnormal_redox_activity | 1.48392736 |
| 45 | MP0008260_abnormal_autophagy | 1.48132059 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.47757426 |
| 47 | MP0003787_abnormal_imprinting | 1.47067542 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.44378561 |
| 49 | MP0000604_amyloidosis | 1.43638241 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.43202161 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.39774514 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.38340996 |
| 53 | MP0008469_abnormal_protein_level | 1.37090711 |
| 54 | MP0004147_increased_porphyrin_level | 1.34827521 |
| 55 | MP0000716_abnormal_immune_system | 1.34249847 |
| 56 | MP0002405_respiratory_system_inflammati | 1.31154399 |
| 57 | MP0002254_reproductive_system_inflammat | 1.29806960 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.29435599 |
| 59 | MP0005360_urolithiasis | 1.29190207 |
| 60 | MP0002139_abnormal_hepatobiliary_system | 1.28993599 |
| 61 | MP0003303_peritoneal_inflammation | 1.28383225 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.26515860 |
| 63 | MP0004484_altered_response_of | 1.24410904 |
| 64 | MP0009764_decreased_sensitivity_to | 1.23766404 |
| 65 | MP0005408_hypopigmentation | 1.19642515 |
| 66 | MP0001851_eye_inflammation | 1.19272466 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19096914 |
| 68 | MP0000372_irregular_coat_pigmentation | 1.18928242 |
| 69 | MP0003011_delayed_dark_adaptation | 1.18555349 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.18319313 |
| 71 | MP0003866_abnormal_defecation | 1.17075653 |
| 72 | MP0003329_amyloid_beta_deposits | 1.15168235 |
| 73 | MP0003763_abnormal_thymus_physiology | 1.14516408 |
| 74 | MP0002398_abnormal_bone_marrow | 1.14314041 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.07976875 |
| 76 | MP0003448_altered_tumor_morphology | 1.06377178 |
| 77 | MP0005085_abnormal_gallbladder_physiolo | 1.04955222 |
| 78 | MP0000343_altered_response_to | 1.04259244 |
| 79 | MP0001666_abnormal_nutrient_absorption | 1.04188004 |
| 80 | MP0002429_abnormal_blood_cell | 1.04182041 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.02730413 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.02417154 |
| 83 | MP0009278_abnormal_bone_marrow | 1.02000697 |
| 84 | MP0005310_abnormal_salivary_gland | 0.99934734 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.98645094 |
| 86 | MP0001853_heart_inflammation | 0.98059290 |
| 87 | MP0004510_myositis | 0.97824523 |
| 88 | MP0002098_abnormal_vibrissa_morphology | 0.97806506 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.97636186 |
| 90 | MP0005166_decreased_susceptibility_to | 0.96859575 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.96746632 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.94204228 |
| 93 | MP0002796_impaired_skin_barrier | 0.94013694 |
| 94 | MP0003252_abnormal_bile_duct | 0.93384101 |
| 95 | MP0000377_abnormal_hair_follicle | 0.92736682 |
| 96 | MP0008004_abnormal_stomach_pH | 0.92365276 |
| 97 | MP0002722_abnormal_immune_system | 0.91202845 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.90399190 |
| 99 | MP0003045_fibrosis | 0.90100103 |
| 100 | MP0005164_abnormal_response_to | 0.89584322 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.89500592 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88629247 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.87758202 |
| 104 | MP0003075_altered_response_to | 0.87511618 |
| 105 | MP0005365_abnormal_bile_salt | 0.86465560 |
| 106 | MP0001764_abnormal_homeostasis | 0.86449347 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.86264026 |
| 108 | MP0000858_altered_metastatic_potential | 0.84855137 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.84631284 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.84631284 |
| 111 | MP0001243_abnormal_dermal_layer | 0.83194823 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.82038660 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.81241198 |
| 114 | MP0003646_muscle_fatigue | 0.80906141 |
| 115 | MP0001873_stomach_inflammation | 0.79986485 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.78198573 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.77920245 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.77751914 |
| 119 | MP0009763_increased_sensitivity_to | 0.76917879 |
| 120 | MP0001881_abnormal_mammary_gland | 0.76899244 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.76340449 |
| 122 | MP0004043_abnormal_pH_regulation | 0.76184077 |
| 123 | MP0005535_abnormal_body_temperature | 0.75796624 |
| 124 | MP0002132_abnormal_respiratory_system | 0.75743489 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.75154048 |
| 126 | MP0004883_abnormal_blood_vessel | 0.75096775 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.74716720 |
| 128 | MP0001542_abnormal_bone_strength | 0.74522364 |
| 129 | MP0005390_skeleton_phenotype | 0.73718732 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.73041671 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.71738183 |
| 132 | MP0000609_abnormal_liver_physiology | 0.71588719 |
| 133 | MP0002928_abnormal_bile_duct | 0.70603745 |
| 134 | MP0005253_abnormal_eye_physiology | 0.69509388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 4.10133800 |
| 2 | Neurofibrillary tangles (HP:0002185) | 3.84931850 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77628216 |
| 4 | Abnormality of macrophages (HP:0004311) | 3.68712738 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 3.50165219 |
| 6 | Chronic otitis media (HP:0000389) | 3.46778219 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.42588497 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.39991991 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.35456741 |
| 10 | Hepatosplenomegaly (HP:0001433) | 3.35303146 |
| 11 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.21547869 |
| 12 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.03334279 |
| 13 | Stomach cancer (HP:0012126) | 3.02849249 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.91823149 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 2.81971443 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.79689672 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.79689672 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 2.79689672 |
| 19 | Myositis (HP:0100614) | 2.77123198 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.73087766 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72952282 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.69303201 |
| 23 | Recurrent skin infections (HP:0001581) | 2.66366909 |
| 24 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.66359652 |
| 25 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.66359652 |
| 26 | Spastic paraparesis (HP:0002313) | 2.65524047 |
| 27 | Orchitis (HP:0100796) | 2.64402207 |
| 28 | Hematochezia (HP:0002573) | 2.63599801 |
| 29 | Axonal loss (HP:0003447) | 2.62304344 |
| 30 | Purpura (HP:0000979) | 2.55387420 |
| 31 | T lymphocytopenia (HP:0005403) | 2.53542157 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.51947192 |
| 33 | Optic neuritis (HP:0100653) | 2.51947192 |
| 34 | Pulmonary infiltrates (HP:0002113) | 2.51474683 |
| 35 | Petechiae (HP:0000967) | 2.51373186 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.46538913 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.45280984 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.45032765 |
| 39 | Alveolar cell carcinoma (HP:0006519) | 2.42282505 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.41769138 |
| 41 | Prolonged neonatal jaundice (HP:0006579) | 2.40746166 |
| 42 | Recurrent viral infections (HP:0004429) | 2.35353995 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.33699048 |
| 44 | Vasculitis (HP:0002633) | 2.33681616 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.30940738 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.29820999 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.29537259 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28992037 |
| 49 | Gingival bleeding (HP:0000225) | 2.28537195 |
| 50 | Hemoptysis (HP:0002105) | 2.26739760 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.26611378 |
| 52 | Premature loss of primary teeth (HP:0006323) | 2.26169116 |
| 53 | Severe combined immunodeficiency (HP:0004430) | 2.25808345 |
| 54 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.24303344 |
| 55 | Abnormal hemoglobin (HP:0011902) | 2.24049994 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.23577515 |
| 57 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23216827 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.22906865 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22906865 |
| 60 | Cerebral hemorrhage (HP:0001342) | 2.21922828 |
| 61 | Abnormality of the prostate (HP:0008775) | 2.19498010 |
| 62 | Stomatitis (HP:0010280) | 2.19207476 |
| 63 | Chest pain (HP:0100749) | 2.18611554 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.17675418 |
| 65 | Abolished electroretinogram (ERG) (HP:0000550) | 2.16938827 |
| 66 | IgG deficiency (HP:0004315) | 2.13962479 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.13838952 |
| 68 | Loss of speech (HP:0002371) | 2.10944990 |
| 69 | Erythroderma (HP:0001019) | 2.10929086 |
| 70 | Thyroiditis (HP:0100646) | 2.09147226 |
| 71 | Neonatal respiratory distress (HP:0002643) | 2.08701449 |
| 72 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07496094 |
| 73 | Urticaria (HP:0001025) | 2.07036681 |
| 74 | Facial diplegia (HP:0001349) | 2.06896207 |
| 75 | Abnormality of the lumbar spine (HP:0100712) | 2.06474679 |
| 76 | Increased density of long bones (HP:0006392) | 2.04788149 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.04659868 |
| 78 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04659868 |
| 79 | Pustule (HP:0200039) | 2.03914451 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 2.02620872 |
| 81 | Anorexia (HP:0002039) | 2.02496969 |
| 82 | Sensory axonal neuropathy (HP:0003390) | 2.01640519 |
| 83 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01217910 |
| 84 | Thick nail (HP:0001805) | 2.00978448 |
| 85 | IgM deficiency (HP:0002850) | 1.99270009 |
| 86 | Paraparesis (HP:0002385) | 1.98848468 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 1.98799458 |
| 88 | Abnormality of dental color (HP:0011073) | 1.96180973 |
| 89 | Agitation (HP:0000713) | 1.95976141 |
| 90 | Encephalitis (HP:0002383) | 1.93779159 |
| 91 | Leukocytosis (HP:0001974) | 1.93494156 |
| 92 | Anhidrosis (HP:0000970) | 1.93418431 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93340166 |
| 94 | Protuberant abdomen (HP:0001538) | 1.93271816 |
| 95 | Keratitis (HP:0000491) | 1.92571456 |
| 96 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91686422 |
| 97 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91686422 |
| 98 | Type II lissencephaly (HP:0007260) | 1.90839615 |
| 99 | Increased IgM level (HP:0003496) | 1.90103976 |
| 100 | Patchy hypopigmentation of hair (HP:0011365) | 1.89937102 |
| 101 | Combined immunodeficiency (HP:0005387) | 1.89282718 |
| 102 | Abnormality of eosinophils (HP:0001879) | 1.88559378 |
| 103 | Stridor (HP:0010307) | 1.87746158 |
| 104 | Steatorrhea (HP:0002570) | 1.87531426 |
| 105 | Increased IgE level (HP:0003212) | 1.87179162 |
| 106 | Arterial thrombosis (HP:0004420) | 1.86936383 |
| 107 | Recurrent bronchitis (HP:0002837) | 1.86812536 |
| 108 | Increased CSF protein (HP:0002922) | 1.86755886 |
| 109 | Meningitis (HP:0001287) | 1.86706461 |
| 110 | Attenuation of retinal blood vessels (HP:0007843) | 1.86640615 |
| 111 | Increased serum ferritin (HP:0003281) | 1.85079980 |
| 112 | Recurrent pneumonia (HP:0006532) | 1.84562377 |
| 113 | Granulocytopenia (HP:0001913) | 1.84560706 |
| 114 | Joint swelling (HP:0001386) | 1.83825443 |
| 115 | Fat malabsorption (HP:0002630) | 1.83734262 |
| 116 | Polyneuropathy (HP:0001271) | 1.83592194 |
| 117 | Progressive neurologic deterioration (HP:0002344) | 1.83036527 |
| 118 | White forelock (HP:0002211) | 1.82866398 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82402808 |
| 120 | Obstructive lung disease (HP:0006536) | 1.81887071 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81887071 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.81259592 |
| 123 | Peritonitis (HP:0002586) | 1.80903413 |
| 124 | Hypothermia (HP:0002045) | 1.80570292 |
| 125 | Onion bulb formation (HP:0003383) | 1.79506268 |
| 126 | Mutism (HP:0002300) | 1.79168180 |
| 127 | Spontaneous hematomas (HP:0007420) | 1.78812683 |
| 128 | Ketoacidosis (HP:0001993) | 1.78609224 |
| 129 | Ileus (HP:0002595) | 1.78427785 |
| 130 | Autoamputation (HP:0001218) | 1.78294841 |
| 131 | Chronic diarrhea (HP:0002028) | 1.77997503 |
| 132 | Premature skin wrinkling (HP:0100678) | 1.77979087 |
| 133 | Hypergammaglobulinemia (HP:0010702) | 1.77636083 |
| 134 | Abnormality of T cells (HP:0002843) | 1.77124590 |
| 135 | Xanthomatosis (HP:0000991) | 1.77096473 |
| 136 | Amyloidosis (HP:0011034) | 1.76729376 |
| 137 | Prolonged bleeding time (HP:0003010) | 1.76280970 |
| 138 | Abnormality of the pleura (HP:0002103) | 1.76097452 |
| 139 | Progressive inability to walk (HP:0002505) | 1.75744907 |
| 140 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75682302 |
| 141 | Systemic lupus erythematosus (HP:0002725) | 1.74951633 |
| 142 | Eosinophilia (HP:0001880) | 1.74770695 |
| 143 | Gangrene (HP:0100758) | 1.74425333 |
| 144 | Congenital stationary night blindness (HP:0007642) | 1.73977468 |
| 145 | Pancreatitis (HP:0001733) | 1.73520523 |
| 146 | Vertigo (HP:0002321) | 1.72891018 |
| 147 | Prostate neoplasm (HP:0100787) | 1.72524224 |
| 148 | Cellulitis (HP:0100658) | 1.72295210 |
| 149 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70305574 |
| 150 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70305574 |
| 151 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70305574 |
| 152 | Renal Fanconi syndrome (HP:0001994) | 1.68890435 |
| 153 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.65154451 |
| 154 | Episodic fever (HP:0001954) | 1.65039339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.22624302 |
| 2 | MST4 | 3.78829030 |
| 3 | EPHB1 | 3.35501727 |
| 4 | PBK | 3.28750930 |
| 5 | OXSR1 | 2.56278812 |
| 6 | FRK | 2.50629319 |
| 7 | MAP4K1 | 2.43798390 |
| 8 | BMPR2 | 2.26038362 |
| 9 | MAP3K14 | 2.17857988 |
| 10 | TESK2 | 1.97421591 |
| 11 | MET | 1.96451080 |
| 12 | TXK | 1.91087382 |
| 13 | LIMK1 | 1.86307954 |
| 14 | TBK1 | 1.84530823 |
| 15 | ERBB3 | 1.79503781 |
| 16 | TRIM28 | 1.78464429 |
| 17 | ADRBK2 | 1.76419836 |
| 18 | EPHA3 | 1.71887704 |
| 19 | IRAK4 | 1.64712740 |
| 20 | PINK1 | 1.62886477 |
| 21 | ITK | 1.62530171 |
| 22 | JAK3 | 1.56673530 |
| 23 | MAPKAPK5 | 1.56544045 |
| 24 | WNK4 | 1.56419515 |
| 25 | BCR | 1.55416148 |
| 26 | MAP4K2 | 1.52736583 |
| 27 | FES | 1.50971347 |
| 28 | BTK | 1.50871055 |
| 29 | IKBKE | 1.48484396 |
| 30 | GRK7 | 1.47638322 |
| 31 | KIT | 1.45762232 |
| 32 | NME2 | 1.45270362 |
| 33 | ERN1 | 1.43139118 |
| 34 | TNIK | 1.42825095 |
| 35 | TYK2 | 1.38419137 |
| 36 | PIM2 | 1.35988098 |
| 37 | FGFR4 | 1.35451037 |
| 38 | IKBKB | 1.34508657 |
| 39 | MAP3K12 | 1.33983199 |
| 40 | LRRK2 | 1.30573394 |
| 41 | STK10 | 1.30547849 |
| 42 | BLK | 1.29244142 |
| 43 | ZAP70 | 1.28940678 |
| 44 | CSK | 1.28380988 |
| 45 | CDK19 | 1.27997054 |
| 46 | CSF1R | 1.25949644 |
| 47 | GRK1 | 1.23661942 |
| 48 | PKN1 | 1.17236027 |
| 49 | TEC | 1.16942953 |
| 50 | BCKDK | 1.15811423 |
| 51 | PDK2 | 1.13247358 |
| 52 | FGFR2 | 1.13082114 |
| 53 | MUSK | 1.11745739 |
| 54 | MAP3K3 | 1.09803011 |
| 55 | TRPM7 | 1.07826892 |
| 56 | MAP3K4 | 1.06542285 |
| 57 | CAMKK2 | 1.06340072 |
| 58 | PRKCQ | 1.04914634 |
| 59 | MAP3K13 | 1.01363783 |
| 60 | EPHA2 | 1.01230897 |
| 61 | CLK1 | 1.01162901 |
| 62 | MAPK15 | 1.00457204 |
| 63 | BRSK2 | 1.00400884 |
| 64 | FER | 1.00159894 |
| 65 | LCK | 0.99676069 |
| 66 | DYRK3 | 0.99170950 |
| 67 | CSNK1G3 | 0.98658176 |
| 68 | STK16 | 0.97021710 |
| 69 | NLK | 0.93572024 |
| 70 | CSNK1A1L | 0.93116510 |
| 71 | SYK | 0.89964066 |
| 72 | DAPK2 | 0.89234928 |
| 73 | DYRK2 | 0.86812350 |
| 74 | STK38L | 0.86255046 |
| 75 | TAOK1 | 0.83591184 |
| 76 | MAP3K5 | 0.83574465 |
| 77 | ACVR1B | 0.83355145 |
| 78 | MAP2K7 | 0.82942751 |
| 79 | MAPK7 | 0.82736984 |
| 80 | EIF2AK3 | 0.82727503 |
| 81 | TAOK3 | 0.82072482 |
| 82 | TNK2 | 0.81338282 |
| 83 | MAP2K3 | 0.81260978 |
| 84 | IRAK1 | 0.79250195 |
| 85 | IRAK3 | 0.77807892 |
| 86 | MST1R | 0.77762714 |
| 87 | RPS6KA5 | 0.76680862 |
| 88 | ROCK2 | 0.76539757 |
| 89 | ADRBK1 | 0.76380027 |
| 90 | BMPR1B | 0.76342708 |
| 91 | FGR | 0.75890086 |
| 92 | PDGFRB | 0.72573685 |
| 93 | TGFBR2 | 0.71490596 |
| 94 | KDR | 0.70642817 |
| 95 | STK24 | 0.70281154 |
| 96 | WNK3 | 0.67849805 |
| 97 | ABL2 | 0.67645061 |
| 98 | LYN | 0.66312456 |
| 99 | GRK6 | 0.65174722 |
| 100 | HCK | 0.64944403 |
| 101 | WNK1 | 0.64725799 |
| 102 | ABL1 | 0.62902065 |
| 103 | CSNK1G1 | 0.61210457 |
| 104 | DYRK1B | 0.61110873 |
| 105 | PIK3CG | 0.60731068 |
| 106 | PIM1 | 0.58201924 |
| 107 | MAP3K6 | 0.58157884 |
| 108 | TESK1 | 0.56991154 |
| 109 | MAP3K2 | 0.56801636 |
| 110 | JAK1 | 0.55861255 |
| 111 | JAK2 | 0.55771788 |
| 112 | FGFR3 | 0.53239511 |
| 113 | YES1 | 0.52645463 |
| 114 | NEK9 | 0.52342372 |
| 115 | PAK3 | 0.52123777 |
| 116 | MAPKAPK2 | 0.51871215 |
| 117 | MAP2K2 | 0.50980033 |
| 118 | HIPK2 | 0.50833814 |
| 119 | NUAK1 | 0.50723123 |
| 120 | PDPK1 | 0.50232614 |
| 121 | MARK3 | 0.49991632 |
| 122 | MAP2K6 | 0.49808334 |
| 123 | IRAK2 | 0.48890779 |
| 124 | CHUK | 0.47687448 |
| 125 | ZAK | 0.44819515 |
| 126 | GRK5 | 0.44307035 |
| 127 | STK4 | 0.43927792 |
| 128 | CAMK2D | 0.43455668 |
| 129 | MOS | 0.42948932 |
| 130 | RPS6KA4 | 0.41371180 |
| 131 | PTK2B | 0.40842241 |
| 132 | PRKCE | 0.40717136 |
| 133 | CAMK2B | 0.39727496 |
| 134 | SIK3 | 0.39253363 |
| 135 | MAP3K11 | 0.38996063 |
| 136 | OBSCN | 0.38421097 |
| 137 | PRKD1 | 0.38215278 |
| 138 | MAP2K1 | 0.37855663 |
| 139 | IGF1R | 0.37563200 |
| 140 | FLT3 | 0.37216281 |
| 141 | CDK6 | 0.36547766 |
| 142 | MATK | 0.34994621 |
| 143 | PRKCD | 0.34734277 |
| 144 | RIPK4 | 0.34690372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.58623192 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.13648314 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.76983575 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.71299989 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.28002523 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.04271222 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.96698525 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76119697 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75447751 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73723500 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.72970307 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72280060 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71560406 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.71182904 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70093995 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.69916500 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59747696 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58129267 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55811287 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.55057660 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.54013168 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52347418 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.50808590 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.49927383 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47097445 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.44833692 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42565869 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41348944 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38315788 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.36700041 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36559635 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30761873 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29397019 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28771063 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28700740 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.28219301 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.26837555 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.24542412 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22003889 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.17464847 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16785157 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14818006 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.13542566 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11932916 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11424872 |
| 46 | Proteasome_Homo sapiens_hsa03050 | 1.10574299 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10064443 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09817549 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09385633 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09318889 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.07891433 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07320466 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.07140596 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05538960 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05178566 |
| 56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04929988 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04330095 |
| 58 | Ribosome_Homo sapiens_hsa03010 | 1.03364355 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 1.01817183 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.01228685 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98896362 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.96528261 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96043815 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92941677 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90611029 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89809511 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89796377 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88536448 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88454174 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85613669 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85101020 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84811001 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84038650 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.83807690 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83169772 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.81183554 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80378847 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79380728 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77649499 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77458128 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76909768 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.76116813 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75995875 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71775002 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67302285 |
| 86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65617563 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64437422 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64188337 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64185013 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63217387 |
| 91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62138510 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61699519 |
| 93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61672211 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.61435030 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.61139683 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58932871 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58807914 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57086433 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56795483 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56724139 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56710402 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54739110 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53123396 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52103291 |
| 105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51197128 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49291459 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46364790 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.46306504 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.44548973 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.44162712 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43506583 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43471462 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.42578858 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42499351 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42184299 |
| 116 | * Endocytosis_Homo sapiens_hsa04144 | 0.40689016 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39124130 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.38158865 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35664889 |
| 120 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35239818 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34742899 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32921819 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28583853 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27537351 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23721431 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.22713611 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21947139 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19617951 |

